The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar.

Autor: Abushanab D; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Al-Marridi W; College of Medicine, QU Health, Qatar University, Doha, Qatar., Al Hail M; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Abdul Rouf PV; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., ElKassem W; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Thomas B; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Alsoub H; Department of Medicine, Hamad Medical Corporation, Doha, Qatar., Ademi Z; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia., Hanssens Y; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Enany RE; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Al-Badriyeh D; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.

Publikováno v: Journal of pharmaceutical policy and practice [J Pharm Policy Pract] 2024 Mar 27; Vol. 17 (1), pp. 2326382. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).

Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.

Autor: Abushanab D; Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Qatar., Gulied A; Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Qatar., Hamad A; Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Qatar., Abu-Tineh M; Department of Medical Oncology-Hematology and Bone Marrow Transplantation Section, National Center for Cancer Care and Research, Hamad Medical Corporation, Qatar., Abdul Rouf PV; Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Qatar., Al Hail M; Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Qatar., El-Kassem W; Pharmacy Department, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Qatar., El Hajj MS; College of Pharmacy, QU Health, Qatar University, Qatar., Al-Badriyeh D; College of Pharmacy, QU Health, Qatar University, Qatar.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Dec; Vol. 29 (8), pp. 1935-1943. Date of Electronic Publication: 2023 Mar 22.

Patterns and outcomes of paracetamol poisoning management in Hamad Medical Corporation, Qatar: A retrospective cohort study.

Autor: Abushanab D; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Gasim M; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Devi D; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Elbdairy M; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Elqasass H; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Ahmed N; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Vincent M; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Abdul Rouf PV; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Mohammed HR; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Hail MA; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Thomas B; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Elkassem W; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Hanssens Y; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Elgassim M; Department of Accident and Emergency, Hamad Medical Corporation, Doha, Qatar., Elmoheen A; Department of Accident and Emergency, Hamad Medical Corporation, Doha, Qatar., Azad A; Department of Accident and Emergency, Hamad Medical Corporation, Doha, Qatar., Mohammed S; Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar., Salem W; Department of Accident and Emergency, Hamad Medical Corporation, Doha, Qatar.

Publikováno v: Medicine [Medicine (Baltimore)] 2023 Sep 22; Vol. 102 (38), pp. e34872.

A case of probable labetalol induced hyperkalaemia in pre-eclampsia.

Autor: Thomas B; Hamad Medical Corporation, Doha, Qatar, binnyinhmc@gmail.com., Abdul Rouf PV, El Kassem W, Al Hail M, Stewart D, Tharannum A, Ahmed A, Al Saadi M

Publikováno v: International journal of clinical pharmacy [Int J Clin Pharm] 2014 Dec; Vol. 36 (6), pp. 1130-3. Date of Electronic Publication: 2014 Nov 05.